革新的がん研究支援室

AMED news

AMED news - Detail

2019.01.30
Prediction of ALK Mutations Mediating ALK-TKIs Resistance and Drug Re-purposing to Overcome the Resistance
A press release from the Japan Agency for Medical Research and Development (AMED):

"Prediction of ALK Mutations Mediating ALK-TKIs Resistance and Drug Re-purposing to Overcome the Resistance"

  Visit AMED website